Impaired of Sexuality in Premenopausal Breast Cancer Patients - Open Journal of Obstetrics and Gynecology

OJOG > Vol.11 No.11, November 2021

Open Journal of Obstetrics and Gynecology

Volume 11, Issue 11 (November 2021)

ISSN Print: 2160-8792 ISSN Online: 2160-8806

Google-based Impact Factor: 0.37 Citations h5-index & Ranking

Impaired of Sexuality in Premenopausal Breast Cancer Patients ()

HTML XML

Download as PDF (Size: 261KB) PP. 1596-1607

DOI: 10.4236/ojog.2021.1111149 137 Downloads 688 Views

Author(s)

Paula Vendruscolo Tozatti^1*, Janete Vettorazzi^1,2,3,4, Nathália Lobato³, Andrea Pires Souto Damin^1,2,3,5

Affiliation(s)

¹Postgraduate Program in Health Sciences: Gynecology and Obstetrics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brasil.
²Department of Gynecology and Obstetrics, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.
³Service of Obstetrics and Gynecology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil.
⁴Nucleus of Studies and Research in Sexuality of Rio Grande do Sul (NEPESEX), CNPq, Porto Alegre, Brasil.
⁵Head of the Mastology Service of the Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil.

ABSTRACT

Introduction: The treatment modalities for Breast cancer may impair the sexual function of women, especially in the pre-menopausal period. Treatment in this group of women has a huge impact in quality of life. The main objective of this study was to evaluate the prevalence of sexual dysfunction (SD) after treatment for breast cancer among women who were premenopausal at the diagnosis of neoplasia. Material and Methods: All women diagnosed with premenopausal breast cancer at one outpatient clinic from March 2019 to September 2020 were selected. Participants answered two sexual function questionnaires (the Female Sexual Function Index [FSFI-19] and Female Sexual Quotient [QS-F]) and a quality of life [QOL] questionnaire [EORTC QLQ-C30]). Sociodemographic and tumor characteristics were also studied. Results: Fifty-eight pre-menopausal women were included. Sexual dysfunction (SD) was observed in 43 participants (74.1%) according to the FSFI-19, while 31 (53.4%) had SD according to the QS-F. The functional and general health scales of the EORTC QLQ-C30 were positively related to the FSFI-19 and QS-F scores, while the symptom scale was negatively related to the FSFI-19 and QS-F scores. There was no relationship between chemotherapy, hormone therapy, or surgery with the FSFI-19 and QSF scores. A diagnosis of depression was negatively related to the total FSFI-19 scores. Conclusion: Pre-menopausal breast cancer women showed high rates of female SD. None breast cancer treatment modality was related to SD. The only studied variable associated with SD was depression.

KEYWORDS

Breast Cancer, Sexuality, Quality of Life, Sexual Dysfunction, Premenopausal Period, FSFI-19, QS-F, EORTC QLQ-C30

Share and Cite:

Tozatti, P. , Vettorazzi, J. , Lobato, N. and Damin, A. (2021) Impaired of Sexuality in Premenopausal Breast Cancer Patients. Open Journal of Obstetrics and Gynecology, 11, 1596-1607. doi: 10.4236/ojog.2021.1111149.

Cited by

No relevant information.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies